Use of prostate‐specific membrane antigen positron‐emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer. (4th August 2020) - Anton, Angelyn; Kamel Hasan, Olfat; Ballok, Zita; Bowden, Patrick; Costello, Anthony J.; Harewood, Laurence; Corcoran, Niall M.; Dundee, Phil; Peters, Justin S.; Lawrentschuk, Nathan; Troy, Andrew; Webb, David; et al.